Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor.
Clinical pharmacokinetics(2015)
Key words
Hepatic Impairment,Plasma Protein Binding,Severe Hepatic Impairment,Moderate Hepatic Impairment,Diacylglycerol Acyltransferase
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined